RE-BVS – Piemonte Repository

Sfoglia per AUTORE
BRUZZONE B
Collezione ASL Città di Torino

Items : 11

Comparison of Different HIV-1 Resistance Interpretation Tools for Next-Generation Sequencing in Italy. in Viruses / Viruses. 2024 Sep 6;16(9):1422. doi: 10.3390/v16091422.

2024
ASL Città di Torino

Armenia D; Carioti L; Micheli V; Bon I; Allice T; Bonura C; Bruzzone B; Bracchitta F; Cerutti F; Giammanco GM; Stefanelli F; Bonifacio MA; Bertoli A; Vatteroni M; Ibba G; Novazzi F; Lipsi MR; Cuomo N; Vicenti I; Ceccherini-Silberstein F; Rossetti B; Bezenchek A; Saladini F; Zazzi M; Santoro MM;

Phylogeography and genomic epidemiology of SARS-CoV-2 in Italy and Europe with newly characterized Italian genomes between February-June 2020. in Scientific reports / Sci Rep. 2022 Apr 6;12(1):5736. doi: 10.1038/s41598-022-09738-0.

2022
ASL Città di Torino

Andreoni M; Mastroianni CM; Nunnari G; Babudieri S; Schiavo R; Orsi A; Caucci S; Cerutti F; Menozzi I; Cirillo D; Tonon G; Miola A; Vicenti I; Francisci D; Callegaro A; Sagnelli C; Brindicci G; Sarmati L; Antonelli G; Rullo EV; Fiore V; Codeluppi M; Bruzzone B; Menzo S; Ghisetti V; Morganti M; Toppo S; Bergna A; Lai A; et alii...

The Longest Persistence of Viable SARS-CoV-2 With Recurrence of Viremia and Relapsing Symptomatic COVID-19 in an Immunocompromised Patient-A Case Study. in Open forum infectious diseases / Open Forum Infect Dis. 2021 Apr 28;8(11):ofab217. doi: 10.1093/ofid/ofab217. eCollection 2021 Nov.

2021
ASL Città di Torino

Sepulcri C; Dentone C; Mikulska M; Bruzzone B; Lai A; Fenoglio D; Bozzano F; Bergna A; Parodi A; Altosole T; Delfino E; Bartalucci G; Orsi A; Di Biagio A; Zehender G; Ballerini F; Bonora S; Sette A; De Palma R; Silvestri G; De Maria A; Bassetti M;

Circulating SARS-CoV-2 variants in Italy, October 2020-March 2021. in Virology journal / Virol J. 2021 Aug 14;18(1):168. doi: 10.1186/s12985-021-01638-5.

2021
ASL Città di Torino

Lai A; Bergna A; Menzo S; Zehender G; Caucci S; Ghisetti V; Rizzo F; Maggi F; Cerutti F; Giurato G; Weisz A; Turchi C; Bruzzone B; Ceccherini Silberstein F; Clementi N; Callegaro A; Sagradi F; Francisci D; Venanzi Rullo E; Vicenti I; Clementi M; Galli M;

Urgent need of rapid tests for SARS CoV-2 antigen detection: Evaluation of the SD-Biosensor antigen test for SARS-CoV-2. in Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology / J Clin Virol. 2020 Nov;132:104654. doi: 10.1016/j.jcv.2020.104654. Epub 2020 Sep 29.

2020
ASL Città di Torino

Bruzzone B; Gregori G; Allice T; Milia MG; Cerutti F; Burdino E; Ghisetti V;

Prevalence of acquired resistance mutations in a large cohort of perinatally infected HIV-1 patients. in Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases / Clin Microbiol Infect. 2019 Nov;25(11):1443-1446. doi: 10.1016/j.cmi.2019.07.004. Epub 2019 Jul 25.

2019
ASL Città di Torino
AOU Novara

Monno L; Callegaro AP; Paolini E; Zoncada A; Pecorari M; Francisci D; Borghi V; Galli L; Vicenti I; Bruzzone B; Taramasso L; Ungaro R; Bonora S; Di Biagio A;

Frequent NS5A and multiclass resistance in almost all HCV genotypes at DAA failures: What are the chances for second-line regimens? in Journal of hepatology / J Hepatol. 2018 Mar;68(3):597-600. doi: 10.1016/j.jhep.2017.09.008. Epub 2017 Sep 20.

2018
ASL Città di Torino

Baldanti F; Gennari W; Galli S; Barbaliscia S; Bertoli A; Zazzi M; Brunetto M; Ghisetti V; Bruzzone B; Coppola N; Pollicino T; Paolucci S; Aragri M; Di Maio VC; Cento V; Raimondo G; Perno CF; Ceccherini-Silberstein F;

CD8(+)CD28(-)CD127(lo)CD39(+) regulatory T-cell expansion: A new possible pathogenic mechanism for HIV infection? in The Journal of allergy and clinical immunology / J Allergy Clin Immunol. 2018 Jun;141(6):2220-2233.e4. doi: 10.1016/j.jaci.2017.08.021. Epub 2017 Nov

2018
ASL Città di Torino

Fenoglio D; Dentone C; Signori A; Di Biagio A; Parodi A; Kalli F; Nasi G; Curto M; Cenderello G; De Leo P; Bartolacci V; Orofino G; Nicolini LA; Taramasso L; Fiorillo E; Orrù V; Traverso P; Bruzzone B; Ivaldi F; Mantia E; Guerra M; Negrini S; Giacomini M; Bhagani S; Filaci G;

Effectiveness, safety, durability and immune recovery in a retrospective, multicentre, observational cohort of ART-experienced, HIV-1-infected patients receiving maraviroc. in International journal of STD & AIDS / Int J STD AIDS. 2017 Oct;28(11):1067-1073. doi: 10.1177/0956462416687828. Epub 2017 Jan 31.

2017
ASL Città di Torino

Dentone C; Sterrantino G; Signori A; Cenderello G; Guerra M; De Leo P; Bartolacci V; Mantia E; Orofino G; Giacomini M; Bruzzone B; Francisci D; Di Biagio A;

First external quality assurance program of the Italian HLA-B*57:01 Network assessing the performance of clinical virology laboratories in HLA-B*57:01 testing. in Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology / J Clin Virol. 2016 May;78:1-3. doi: 10.1016/j.jcv.2016.02.020. Epub 2016 Feb 23.

2016
ASL Città di Torino

Meini G; Dello Russo C; Allice T; Barresi R; D'Arrigo R; Falasca F; Lipsi MR; Paolucci S; Zanussi S; Antonetti R; Baldanti F; Basaglia G; Bruzzone B; Polilli E; Ghisetti V; Pucillo LP; Turriziani O; Pirazzoli A; Navarra P; Zazzi M;

Relationship between innate immunity, soluble markers and metabolic-clinical parameters in HIV+ patients ART treated with HIV-RNA<50 cp/mL. in Journal of the International AIDS Society / J Int AIDS Soc. 2014 Nov 2;17(4 Suppl 3):19718. doi: 10.7448/IAS.17.4.19718. eCollection 2014.

2014
ASL Città di Torino

Dentone C; Fenoglio D; Signori A; Cenderello G; Parodi A; Bozzano F; Guerra M; De Leo P; Bartolacci V; Mantia E; Orofino G; Kalli F; Marras F; Fraccaro P; Giacomini M; Cassola G; Bruzzone B; Ferrea G; Viscoli C; Filaci G; De Maria A; Di Biagio A;